News

ShopRite offering free prenatal vitamins

BY Antoinette Alexander

KEASBEY, N.J. — Grocery chain ShopRite is offering free prenatal vitamins to further help shoppers live healthier lives and prepare for a healthy baby.

ShopRite customers can receive a free 30-day supply of Prenatal Plus or Prenatal Plus FE vitamins with a valid prescription. ShopRite also offers free 30-day supplies of select generic diabetes drugs and free 14-day supplies of select generic antibiotics. Other generic prescriptions start as low as $3.99 for a 30-day supply.

There are no membership fees or insurance required to benefit from these savings.

ShopRite customers also can take advantage of the pharmacy’s staff of pharmacists, who are readily available to answer any questions. Furthermore, select ShopRite stores also feature in-store dietitians, who can help expecting mothers plan a healthy diet when eating for two. ShopRite’s retail dietitians offer their services to all customers free of charge.

In related news, ShopRite also offers free children’s prescription multivitamins, available in tablets or drops.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
News

P&G Beauty names 2011 All-Around World Champion Jordyn Wieber as ambassador

BY Antoinette Alexander

CINCINNATI — Procter & Gamble has announced that Jordyn Wieber, reigning All-Around World Champion, will serve as an ambassador for P&G Beauty brands, including CoverGirl, Head & Shoulders, Olay and Venus.

Wieber will join fellow teammate Alicia Sacramone as P&G Beauty ambassador, expanding on her existing partnership with P&G and the company’s sponsorship of Team USA during the London 2012 Olympic Games.

As part of Wieber’s ambassador role, she will support P&G Beauty’s recent pledge to donate $400,000 to the P&G|Team USA Youth Sports Fund, created to support youth sports programs across the country. In addition to Wieber’s partnership with P&G Beauty, she will continue to support P&G’s “Thank you, Mom” campaign.

"We are thrilled to align with such a young, talented athlete who continues to inspire her peers to achieve their personal best,” stated Gina Drosos, group president of P&G Beauty. “Hearing that Jordyn relies on her favorite P&G Beauty brands like CoverGirl and Olay for all of her big moments, whether it is a competition or prom, is a true testament of our commitment to help women face the world with confidence. We’re proud to support her as she continues her Olympic Games journey.”

Wieber set her goal to become an Olympic Games athlete at the age of 10 years old when she earned the title of elite gymnast, only four years after she started competing. Now 16 years old and a member of the U.S. Women’s Senior National Team, she already has won her third American Cup all-around championship, two all-around titles at the Visa National Championships and the all-around title at the World Championships.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
News

Bristol-Myers Squibb buys Amylin for $5.3 billion

BY Alaric DeArment

NEW YORK — Bristol-Myers Squibb is acquiring Amylin Pharmaceuticals, the drug maker said Friday.

Bristol announced that it would acquire Amylin for $5.3 billion, or $31 per share. The total value of the acquisition is about $7 billion, including $1.7 billion in Amylin’s contractual payment and debt obligations.

"Amylin’s innovative diabetes portfolio, talented people and state-of-the-art manufacturing facility complement our long-standing leadership in metabolic," Bristol CEO Lamberto Andreotti said. "We are pleased to be strengthen the portfolio we have built to help patients with diabetes by building on the success Amylin has had with its GLP-1 franchise." GLP-1 agonists are a class of drugs used to treat Type 2 diabetes.

The New York-based drug maker also said that it would expand a diabetes drug development deal with AstraZeneca that the companies entered in 2007. AstraZeneca will pay $3.4 billion to Amylin once the acquisition deal is complete. Together with former partner Eli Lilly, Amylin developed the Type 2 diabetes drugs Byetta (exenatide) and its long-acting form, Bydureon.


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?